SHL Telemedicine Ltd. (SWX:SHLTN)

Market Cap	26.72M
Revenue (ttm)	51.45M
Net Income (ttm)	-25.46M
Shares Out	16.39M
EPS (ttm)	-1.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,469
Average Volume	3,892
Open	1.520
Previous Close	1.520
Day's Range	1.500 - 1.630
52-Week Range	1.110 - 3.850
Beta	0.22
RSI	40.88
Earnings Date	Sep 11, 2025

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional. It also provides preventative healthcare, including annual medical check-ups that include comprehensive laboratory tests, stress ECG tests, eye exams, and others; witness services for medical experts and medical committees,...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1986
• Employees: 526
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SHLTN

Financial Performance

In 2024, SHL Telemedicine's revenue was $56.78 million, a decrease of -0.52% compared to the previous year's $57.08 million. Losses were -$28.10 million, 298.2% more than in 2023.

Financial numbers in USD